Citadel Advisors’s ContraFect Corporation CFRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-453
Closed -$111K 14313
2022
Q2
$111K Buy
+453
New +$128K ﹤0.01% 11317
2022
Q1
Sell
-235
Closed -$49K 15314
2021
Q4
$49K Sell
235
-205
-47% -$56.3K ﹤0.01% 13265
2021
Q3
$143K Sell
440
-51
-10% -$15.9K ﹤0.01% 12437
2021
Q2
$173K Buy
491
+67
+16% +$21.9K ﹤0.01% 12343
2021
Q1
$163K Buy
+424
New +$183K ﹤0.01% 11950

Other funds holding CFRX

Citadel Advisors's CFRX Position: Q1 2023 in Review

Citadel Advisors sold out of ContraFect Corporation (CFRX) in Q1 2023, closing a stake of 940 shares — an estimated $7.21K sold.

Citadel Advisors first reported a position in CFRX in Q3 2017 and held it in 12 quarters. The position peaked at $314K in Q2 2021. 19 funds tracked by Wall St. Rank hold CFRX as of Q1 2023.

  • Citadel Advisors reported no remaining ContraFect Corporation position as of Q1 2023 after selling out during the quarter.
  • Citadel Advisors sold 940 ContraFect Corporation shares in Q1 2023, an estimated $7.21K.
  • Citadel Advisors first reported a position in ContraFect Corporation in Q3 2017 and held it in 12 quarters.
  • Citadel Advisors's ContraFect Corporation position peaked at $314K in Q2 2021.
  • 19 funds tracked by Wall St. Rank held ContraFect Corporation as of Q1 2023.

Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.